Clinical assessment
Neck exam, symptom review, family history, radiation exposure history, voice changes and thyroid nodule features help guide testing.
Thyroid Cancer Education · Ultrasound · FNA · Bethesda · TNM Staging
Thyroid Cancer Diagnosis & Staging
Thyroid cancer diagnosis and staging help determine whether a thyroid nodule is benign or malignant, identify the cancer type, evaluate lymph nodes, assess spread, and guide treatment planning. Evaluation may include thyroid ultrasound, TSH blood testing, fine-needle aspiration biopsy, Bethesda cytology, molecular testing, pathology and TNM staging.
Educational information only. This page does not provide diagnosis, screening
instructions, treatment recommendations or medical advice.
Ultrasound
TSH
FNA
Bethesda
TNM
Diagnosis Overview
How thyroid cancer may be diagnosed
Thyroid cancer evaluation often begins after a thyroid nodule, neck lump, enlarged lymph node, hoarseness, swallowing change or imaging finding. Diagnosis usually combines clinical assessment, ultrasound, blood tests and biopsy for selected nodules.
Ultrasound and blood tests
Thyroid ultrasound evaluates nodules and neck lymph nodes. TSH and thyroid hormone tests help assess thyroid function.
FNA, cytology and staging
Fine-needle aspiration biopsy may be used for selected nodules. Cytology, pathology and imaging help define cancer type and stage.
Diagnosis Pathway
Common steps in thyroid cancer evaluation
Thyroid cancer diagnosis depends on nodule size, ultrasound appearance, lymph-node findings, symptoms, thyroid function, cytology and pathology.
1
Neck exam and symptom review
A clinician may review thyroid nodules, neck lump, hoarseness, swallowing changes, breathing pressure, cough, neck lymph nodes and risk factors.
2
TSH and thyroid blood tests
TSH and thyroid hormone testing help determine whether the thyroid is overactive, underactive or functioning normally. These tests do not diagnose cancer alone.
3
Thyroid ultrasound
Ultrasound evaluates nodule size, solid or cystic structure, echogenicity, margins, calcifications, shape and nearby lymph nodes.
4
Fine-needle aspiration biopsy
Selected nodules may be sampled with a thin needle, often under ultrasound guidance, to collect cells for cytology.
5
Bethesda cytology result
Cytology results are commonly reported using the Bethesda System, which helps categorize thyroid nodule cancer risk and next-step planning.
6
Pathology, molecular testing and staging
Surgery pathology, lymph-node assessment, imaging and selected molecular tests may help determine cancer type, risk group and stage.
Diagnostic Map
Exam
TSH
Ultrasound
FNA
Bethesda
Diagnostic Tests
Tests used in thyroid cancer diagnosis
No single test explains every case. Doctors may combine thyroid function tests, ultrasound, biopsy, cytology, molecular testing, pathology and additional imaging.
Physical exam
Exam may assess thyroid size, nodule location, neck lymph nodes, voice changes, swallowing symptoms and signs of thyroid dysfunction.
TSH blood test
TSH helps evaluate thyroid function and may guide whether a thyroid scan or ultrasound-first evaluation is appropriate.
Thyroid ultrasound
Ultrasound describes nodule size, composition, suspicious features and whether nearby lymph nodes appear abnormal.
Fine-needle aspiration
FNA biopsy collects thyroid nodule cells for cytology and is commonly performed under ultrasound guidance.
Bethesda cytology
The Bethesda System groups FNA results into categories such as benign, atypia, suspicious or malignant.
Molecular testing
Selected indeterminate nodules may be tested for molecular alterations such as BRAF, RAS, RET, NTRK or other markers.
Calcitonin and CEA
These markers may be relevant when medullary thyroid cancer is suspected or confirmed.
CT, MRI or nuclear imaging
Additional imaging may be used when there is concern for local invasion, advanced disease, distant spread or complex surgical planning.
Bethesda
Benign
Atypia
Suspicious
Malignant
Bethesda Cytology
What the Bethesda result means
Bethesda cytology is a reporting system for thyroid FNA biopsy results. It helps communicate the likelihood of malignancy and whether follow-up, repeat FNA, molecular testing or surgery may be discussed.
Benign category
Usually suggests a low cancer risk and may lead to ultrasound follow-up depending on nodule features.
Indeterminate categories
Atypia, follicular lesion or follicular neoplasm categories may need repeat biopsy or molecular testing.
Suspicious or malignant categories
These results usually lead to specialist evaluation and treatment-planning discussion.
TNM Staging
How thyroid cancer staging works
Thyroid cancer staging commonly uses the AJCC TNM system. TNM describes tumor extent, lymph-node involvement and distant metastasis. Age and cancer type also affect staging rules for some thyroid cancer groups.
T
Tumor extent
Describes tumor size, whether it is limited to the thyroid and whether it extends into nearby tissues.
N
Lymph nodes
Describes whether thyroid cancer has spread to nearby cervical or upper mediastinal lymph nodes.
M
Distant metastasis
Describes whether cancer has spread to distant organs or sites, such as lungs or bone.
TNM Stage
T
N
M
Age
Type
Stage Groups
Thyroid cancer stage concepts
Thyroid cancer stage grouping depends on cancer type. Differentiated thyroid cancer, medullary thyroid cancer and anaplastic thyroid cancer have different staging details.
Differentiated thyroid cancer
Includes papillary and follicular thyroid cancers. Stage rules consider age, tumor extent, lymph nodes and distant metastasis.
Medullary thyroid cancer
Staging is based on tumor size or extension, lymph nodes and distant metastasis, with C-cell biology and calcitonin context.
Anaplastic thyroid cancer
Anaplastic thyroid cancer is considered advanced by definition and is staged separately from differentiated thyroid cancers.
Recurrent thyroid cancer
Recurrent disease means cancer has returned after treatment and may be local, regional or distant.
Risk Stratification
Stage is not the same as recurrence risk
Thyroid cancer evaluation may include both stage and recurrence-risk grouping. Stage estimates extent and survival context, while risk stratification estimates likelihood of persistent or recurrent disease.
Low
Lower recurrence-risk features
Small localized tumors, favorable pathology and no concerning spread may suggest lower recurrence risk.
Int
Intermediate-risk features
Lymph-node involvement, aggressive variants or selected invasion patterns may increase recurrence risk.
High
Higher-risk features
Gross invasion, incomplete resection, distant metastasis or aggressive pathology may suggest higher risk.
Follow
Response-to-therapy follow-up
Follow-up may use thyroglobulin, calcitonin, ultrasound, imaging and clinical assessment depending on type.
Risk Map
Stage
Nodes
Pathology
Markers
Follow-up
Pathology
What a thyroid cancer pathology report can show
Pathology helps confirm cancer type, tumor size, invasion, lymph-node involvement, margins and selected molecular features.
Tumor type
Papillary, follicular, oncocytic/Hürthle cell, medullary, poorly differentiated or anaplastic thyroid cancer.
Tumor size and extension
Whether tumor is limited to the thyroid or extends into nearby tissues.
Margins
Whether cancer cells are close to or present at the edge of removed tissue.
Lymph nodes
Number of lymph nodes examined, number involved and size or extranodal extension if reported.
Vascular or capsular invasion
Important for follicular-pattern tumor classification and risk assessment.
Molecular markers
BRAF, RAS, RET, NTRK, TERT, TP53 or other markers may be reported in selected cases.
Simple Summary
Thyroid cancer diagnosis and staging in simple terms
Diagnosis identifies whether a thyroid nodule is cancer. Staging explains tumor extent, lymph-node involvement and whether cancer has spread.
How is thyroid cancer usually evaluated?
Evaluation may include neck exam, TSH blood test, thyroid ultrasound, fine-needle aspiration biopsy, Bethesda cytology, molecular testing, pathology and staging imaging.
What does FNA mean?
FNA means fine-needle aspiration. It uses a thin needle to collect cells from a thyroid nodule for cytology review.
What does TNM staging mean?
TNM describes tumor extent, lymph nodes and distant metastasis. Thyroid cancer stage grouping also depends on cancer type and, for differentiated thyroid cancer, age.
FAQ
FAQ: Thyroid Cancer Diagnosis & Staging
Clear answers to common diagnosis and staging search questions.
How is thyroid cancer diagnosed?
Thyroid cancer evaluation may include physical exam, TSH blood testing, thyroid ultrasound, fine-needle aspiration biopsy, Bethesda cytology, molecular testing, pathology and imaging when needed.
What is a thyroid FNA biopsy?
Fine-needle aspiration biopsy uses a thin needle to collect cells from a thyroid nodule. It is often performed with ultrasound guidance.
What is the Bethesda System?
The Bethesda System is a reporting system for thyroid FNA cytology that groups biopsy results into categories to help estimate cancer risk and guide next steps.
How is thyroid cancer staged?
Thyroid cancer is commonly staged using the AJCC TNM system, which describes tumor extent, lymph-node involvement and distant metastasis.
Is this page medical advice?
No. This page is educational only and does not replace consultation with a qualified healthcare professional.
References
Scientific References
Authoritative sources used to support this thyroid cancer diagnosis and staging page.
- American Cancer Society. Tests for thyroid cancer and thyroid cancer staging.
- National Cancer Institute. Thyroid cancer treatment PDQ and TNM staging information.
- American Thyroid Association. Fine needle aspiration biopsy of thyroid nodules.
- American Thyroid Association. Bethesda System context for thyroid nodule cytology.
- Peer-reviewed and clinical literature on thyroid ultrasound, FNA cytology, molecular testing and thyroid cancer risk stratification.